Salix Pharmaceuticals, Inc.Usage: Xifaxan treats travelers' diarrhea caused by noninvasive E. coli in adults and patients 12+, reduces risk of overt hepatic encephalopathy recurrence in adults, and treats irritable bowel syndrome with diarrhea (IBS-D) in adults.